Unity Biotechnology logo
Unity Biotechnology UBX
$ 1.16 -0.85%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Unity Biotechnology Income Statement 2011-2024 | UBX

Annual Income Statement Unity Biotechnology

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

22.2 M 39.5 M 6.75 M 30.4 M 266 M 323 M - 670 M - - - - -

Shares

14.8 M 9.49 M 5.58 M 5.09 M 43.6 M 28.3 M - 41.9 M - - - - -

Historical Prices

1.5 4.16 1.21 5.97 5.9 11.4 - - - - - - -

Net Income

-39.9 M -44.5 M -60.7 M -93.8 M -82.2 M -76.4 M -44.7 M -30.4 M - - - - -

Revenue

- 236 K 4.78 M - - - 1.38 M - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-44.7 M -57.6 M -56.7 M -93.9 M -89.7 M -79.5 M -45.6 M -18.8 M - - - - -

Interest Expense

2.45 M 3.56 M 3.18 M 1.29 M - -245 K -103 K - - - - - -

EBITDA

-43.5 M -55.4 M -53.8 M -90.5 M -88.3 M -72.7 M -44.3 M -9.31 M - - - - -

Operating Expenses

44.7 M 57.8 M 61.4 M 93.9 M 91 M 74.9 M - - - - - - -

General and Administrative Expenses

19 M 20.9 M 23.1 M 24 M 20 M 16 M 9.62 M 5.14 M - - - - -

All numbers in USD currency

Quarterly Income Statement Unity Biotechnology

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

16.8 M 16.8 M 16.8 M 16.8 M 14.6 M 14.4 M 14.3 M 14.2 M 10.1 M 6.92 M 6.75 M 6.3 M 5.54 M 54.9 M 54.2 M 53.3 M 52.5 M 49.7 M 47.5 M 47.2 M 43 M 42.4 M 42.2 M 42.4 M 41.1 M 26.3 M 3.44 M 4.83 M 3.24 M 3.15 M 3.08 M - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-6.48 M -5.28 M -5.79 M - -14.8 M -15.5 M -5.28 M - -13.7 M -13.1 M -18.9 M - -16.4 M -17.8 M -15.8 M -19.6 M -27.6 M -18.7 M -28 M -18 M -21.7 M -23.7 M -18.8 M -21.9 M -18.3 M -20 M -16.1 M -12.5 M -11.8 M -11.4 M -8.93 M - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - 236 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-6.6 M -6.98 M -7.6 M - -14.6 M -11.8 M -10.6 M - -13.1 M -12.3 M -18.3 M - -14.8 M -17 M -14.9 M -18.8 M -24.6 M -23.3 M -27.2 M -23.1 M -22.4 M -24.5 M -19.7 M -22.8 M -19.4 M -20.8 M -16.5 M -12.8 M -12.1 M -11.7 M -9.04 M - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

-60 K -61 K - - 566 K 883 K 1 M - 866 K 894 K 808 K - 792 K 784 K 775 K - 499 K - - - -112 K -103 K -36 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -7.37 M - - - -10.2 M - -11.4 M -11 M -17.6 M - -12.6 M -15.5 M -14.2 M -18.8 M -22 M -21.5 M -26.3 M -23.1 M -20.4 M -23.2 M -19.1 M -22.8 M -17.8 M -19.8 M -16 M -12.8 M -11.2 M -11.3 M -8.95 M - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

6.6 M 6.98 M 7.6 M - 14.6 M 11.8 M 10.6 M - 13.1 M 12.5 M 18.3 M - 14.8 M 17 M 14.9 M - 24.6 M 23.3 M 27.2 M - 22.4 M 24.5 M 19.7 M - 19.4 M 20.8 M 16.5 M - 12.1 M 11.7 M 9.04 M - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

3.82 M 3.52 M 3.88 M - 4.35 M 5.41 M 4.8 M - 4.92 M 4.94 M 5.81 M - 5.75 M 5.98 M 6.23 M - 6.53 M 6.32 M 5.95 M - 5.69 M 4.97 M 4.48 M - 4.39 M 3.84 M 3.46 M - 2.48 M 2.48 M 2.07 M - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency